Precigen, Inc. (PGEN) Financials

PGEN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 151.0 million 41.6 million
2023-09-30 190.7 million 43.0 million
2023-06-30 207.5 million 41.3 million
2023-03-31 241.5 million 57.4 million

PGEN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -16.8 million 8.6 million
2023-09-30 -17.2 million 2.3 million
2023-06-30 -15.9 million 2.2 million
2023-03-31 -18.5 million 3.1 million

PGEN Net Income

No data available :(

PGEN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 62.9 million - 7.1 million
2023-09-30 73.8 million - 7.4 million
2023-06-30 88.4 million - 8.0 million
2023-03-31 104.1 million - 7.9 million

PGEN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 248.9 million
2023-09-30 248.5 million
2023-06-30 248.0 million
2023-03-31 229.8 million

PGEN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.0 million 13.0 million 10.3 million -
2023-09-30 236000 12.6 million 9.2 million -
2023-06-30 101000 11.9 million 9.3 million -
2023-03-31 154000 12.2 million 11.6 million -

PGEN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.2 million 2.6 million
2023-09-30 16.7 million 1.5 million
2023-06-30 1.8 million 1.7 million
2023-03-31 1.9 million 1.5 million

PGEN

Price: $1.41

52 week price:
0.84
1.88

Earnings Per Share: -0.39 USD

P/E Ratio: -3.84

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 4.3 million

Market Capitalization: 348.5 million

Links: